Ghost Tree Capital as of March 31, 2017
Portfolio Holdings for Ghost Tree Capital
Ghost Tree Capital holds 62 positions in its portfolio as reported in the March 2017 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| SPDR S&P Biotech (XBI) | 11.6 | $62M | 900k | 69.34 | |
| iShares Russell 2000 Index (IWM) | 6.4 | $34M | 250k | 137.48 | |
| Spdr S&p 500 Etf (SPY) | 4.4 | $24M | 100k | 235.74 | |
| ACADIA Pharmaceuticals (ACAD) | 3.6 | $19M | 557k | 34.38 | |
| Dbv Technologies S A (DBVT) | 3.3 | $18M | 500k | 35.22 | |
| Spectranetics Corporation | 2.6 | $14M | 480k | 29.12 | |
| Avexis | 2.5 | $13M | 175k | 76.03 | |
| Neurocrine Biosciences (NBIX) | 2.4 | $13M | 300k | 43.30 | |
| Clovis Oncology | 2.4 | $13M | 200k | 63.67 | |
| BioCryst Pharmaceuticals (BCRX) | 2.4 | $13M | 1.5M | 8.40 | |
| Seattle Genetics | 2.3 | $13M | 200k | 62.86 | |
| Zimmer Holdings (ZBH) | 2.3 | $12M | 100k | 122.11 | |
| Boston Scientific Corporation (BSX) | 2.1 | $11M | 450k | 24.87 | |
| Spark Therapeutics | 2.0 | $11M | 200k | 53.34 | |
| Acceleron Pharma | 2.0 | $11M | 400k | 26.47 | |
| Epizyme | 1.9 | $10M | 600k | 17.15 | |
| Aerie Pharmaceuticals | 1.9 | $10M | 220k | 45.35 | |
| Vertex Pharmaceuticals Incorporated (VRTX) | 1.8 | $9.8M | 90k | 109.36 | |
| Immunomedics | 1.8 | $9.7M | 1.5M | 6.47 | |
| Merck & Co (MRK) | 1.8 | $9.5M | 150k | 63.54 | |
| Endologix | 1.8 | $9.4M | 1.3M | 7.24 | |
| Enanta Pharmaceuticals (ENTA) | 1.7 | $9.2M | 300k | 30.80 | |
| NuVasive | 1.7 | $9.0M | 120k | 74.68 | |
| Lion Biotechnologies | 1.7 | $8.9M | 1.2M | 7.45 | |
| Aduro Biotech | 1.6 | $8.6M | 800k | 10.75 | |
| Puma Biotechnology (PBYI) | 1.6 | $8.4M | 225k | 37.20 | |
| GenMark Diagnostics | 1.6 | $8.3M | 650k | 12.82 | |
| Bristol Myers Squibb (BMY) | 1.5 | $8.2M | 150k | 54.38 | |
| Nanostring Technologies (NSTGQ) | 1.5 | $7.9M | 400k | 19.87 | |
| Portola Pharmaceuticals | 1.5 | $7.8M | 200k | 39.19 | |
| Tesaro | 1.4 | $7.7M | 50k | 153.88 | |
| Agios Pharmaceuticals (AGIO) | 1.4 | $7.3M | 125k | 58.40 | |
| Sage Therapeutics (SAGE) | 1.3 | $7.1M | 100k | 71.07 | |
| Novadaq Technologies | 1.3 | $7.0M | 900k | 7.79 | |
| Ra Pharmaceuticals | 1.2 | $6.4M | 300k | 21.29 | |
| Acorda Therapeutics | 1.2 | $6.3M | 300k | 21.00 | |
| K2m Group Holdings | 1.1 | $5.8M | 285k | 20.51 | |
| Wright Medical Group Nv | 1.1 | $5.8M | 185k | 31.12 | |
| Prothena (PRTA) | 1.0 | $5.6M | 100k | 55.79 | |
| NxStage Medical | 1.0 | $5.4M | 200k | 26.83 | |
| Shire | 1.0 | $5.2M | 30k | 174.23 | |
| Entellus Medical Cm | 1.0 | $5.2M | 375k | 13.80 | |
| Incyte Corporation (INCY) | 0.9 | $4.7M | 35k | 133.66 | |
| Blueprint Medicines (BPMC) | 0.8 | $4.0M | 100k | 39.99 | |
| Zogenix | 0.7 | $4.0M | 365k | 10.85 | |
| Aquinox Pharmaceuticals | 0.7 | $3.8M | 225k | 16.69 | |
| Collegium Pharmaceutical Inc Common Stock Usd (COLL) | 0.7 | $3.8M | 375k | 10.06 | |
| Rigel Pharmaceuticals (RIGL) | 0.7 | $3.6M | 1.1M | 3.31 | |
| IRIDEX Corporation (IRIX) | 0.6 | $3.0M | 250k | 11.87 | |
| Intra Cellular Therapies (ITCI) | 0.5 | $2.4M | 150k | 16.25 | |
| Dermira | 0.4 | $2.2M | 65k | 34.11 | |
| Cymabay Therapeutics | 0.4 | $2.2M | 500k | 4.30 | |
| Conformis | 0.4 | $2.1M | 400k | 5.22 | |
| Ptc Therapeutics I (PTCT) | 0.4 | $2.0M | 200k | 9.84 | |
| D Stemline Therapeutics | 0.4 | $1.9M | 225k | 8.55 | |
| CurrencyShares Swiss Franc Trust | 0.3 | $1.8M | 19k | 95.08 | |
| Zosano Pharma | 0.3 | $1.8M | 940k | 1.90 | |
| Mirati Therapeutics | 0.2 | $895k | 172k | 5.20 | |
| AVEO Pharmaceuticals | 0.2 | $885k | 1.5M | 0.59 | |
| Foamix Pharmaceuticals | 0.1 | $619k | 125k | 4.95 | |
| Xenon Pharmaceuticals (XENE) | 0.1 | $600k | 150k | 4.00 | |
| Akari Therapeutics | 0.1 | $516k | 47k | 11.07 |
